CA4 antibodies target human carbonic anhydrase IV, encoded by the CA4 gene. This enzyme is anchored to cell membranes via glycosylphosphatidylinositol (GPI) and is critical for catalyzing CO₂ hydration in tissues like the kidney, lung, and brain . CA4 overexpression has been linked to tumor progression, making it a focus in cancer biomarker research .
Immunohistochemistry (IHC): CA4 antibodies (e.g., ab236315) detect CA4 in paraffin-embedded human liver cancer tissues at dilutions up to 1:100 .
Western Blot (WB): Antibodies like ab239505 identify CA4 in rat lung and brain lysates at 2 µg/mL, producing a predicted 35 kDa band .
Immunofluorescence (IF): Used to localize CA4 in HeLa cells, revealing cytoplasmic and membranous expression .
Cancer Biomarker: High CA4 expression correlates with poor prognosis in renal cell carcinoma, lower-grade glioma, and lung adenocarcinoma .
Therapeutic Targeting: Preclinical studies explore CA4 antibodies for antibody-drug conjugates (ADCs), leveraging their tumor-specific binding .
Biomarker Validation: Ongoing studies aim to standardize CA4 as a diagnostic marker across carcinomas .
ADC Development: Third-generation ADCs with site-specific CA4 antibody conjugation show promise for reduced immunogenicity and enhanced cytotoxicity .
Mechanistic Studies: Research explores CA4’s role in tumor microenvironment acidification and immune evasion .
KEGG: ath:AT1G66410
UniGene: At.20495
Carbonic Anhydrase 4 (CA4) is a membrane-bound enzyme that catalyzes the reversible hydration of carbon dioxide into bicarbonate and protons. This function is essential for maintaining intracellular and extracellular pH homeostasis . CA4 plays crucial roles in multiple physiological processes, including:
Stimulating the sodium/bicarbonate transporter activity of SLC4A4 that functions in pH regulation
Facilitating acid overload removal from the retina and retina epithelium
Mediating acid release in the choriocapillaris in the choroid
The significance of CA4 in pH regulation makes it an important research target for understanding physiological processes and developing therapeutic approaches for related disorders.
Several detection methods can be employed with CA4 antibodies, each with specific advantages for different research questions:
| Method | Application | Key Considerations | Sensitivity |
|---|---|---|---|
| Immunohistochemistry (IHC-P) | Tissue localization | Requires validated antibodies for paraffin-embedded samples | Moderate |
| Immunocytochemistry/Immunofluorescence (ICC/IF) | Cellular localization | Enables co-staining with other markers | High |
| Western Blotting | Protein expression quantification | Size verification | Moderate-High |
| Flow Cytometry | Cell population analysis | Requires cell permeabilization for intracellular targets | High |
Based on validated results, CA4 antibodies have demonstrated compatibility with IHC-P and ICC/IF techniques for human samples . For example, immunofluorescence staining using CA4 antibodies can be performed on fixed cells with appropriate permeabilization using 0.2% Triton X-100 and blocking with 10% normal serum .
When evaluating CA4 antibody specificity, researchers should implement a multi-faceted validation approach:
Positive and negative controls: Use tissues or cell lines with known CA4 expression profiles
Western blot verification: Confirm the antibody detects a protein of the expected molecular weight
Knockdown/knockout validation: Compare staining between wild-type and CA4-depleted samples
Cross-reactivity testing: Ensure the antibody doesn't recognize other carbonic anhydrase family members
Blocking peptide competition: Competitive inhibition with the immunizing peptide should abolish specific staining
The specificity of commercially available CA4 antibodies can vary significantly. For example, some antibodies are developed using recombinant fragment proteins within human CA4 amino acids 50-200 as immunogens , which helps ensure specificity for this particular isoform.
Optimized immunofluorescence protocols for CA4 antibodies require attention to several key parameters:
Fixation: 4% formaldehyde provides good antigen preservation while maintaining cellular structure
Permeabilization: 0.2% Triton X-100 enables antibody access to intracellular targets
Blocking: 10% normal goat serum effectively reduces background signal
Primary antibody incubation: Overnight at 4°C at dilutions between 1:50-1:100 typically yields optimal signal-to-noise ratios
Secondary antibody selection: Alexa Fluor 488-conjugated AffiniPure Goat Anti-Rabbit IgG(H+L) provides strong fluorescent signal with minimal background
Counterstaining: DAPI for nuclear visualization complements CA4 staining
Researchers should note that CA4, being a membrane-bound enzyme, often displays a characteristic peripheral staining pattern that should be considered when evaluating staining quality.
When using CA4 antibodies to investigate pH regulation mechanisms, researchers should consider the following methodological approaches:
Live-cell imaging: Combine CA4 immunostaining with pH-sensitive fluorescent probes (e.g., BCECF, pHrodo) to correlate CA4 localization with dynamic pH changes
Co-immunoprecipitation: Use CA4 antibodies to pull down protein complexes to identify interacting partners involved in pH regulation pathways
Proximity ligation assays: Detect in situ interactions between CA4 and other components of pH regulatory machinery
Activity assays: Couple CA4 antibodies with enzymatic activity measurements to correlate protein levels with functional outcomes
Research indicates that CA4 may stimulate the sodium/bicarbonate transporter activity of SLC4A4, highlighting the importance of studying functional interactions in pH homeostasis systems .
Developing agonist or antagonist antibodies against CA4 requires understanding several key concepts:
Epitope mapping: Identify binding sites that could affect enzyme activity or protein-protein interactions
Functional screening assays: Design high-throughput systems that can detect changes in CA4 enzymatic activity or downstream signaling
Validation in physiological contexts: Confirm antibody effects in relevant cell types where CA4 naturally functions
Recent advances in developing agonist antibodies against other targets provide valuable methodological insights. Function-based screening approaches have proven superior to traditional affinity-based selection for identifying antibodies with desired biological activity . For example, researchers have developed systems combining reporter cells with antibody-expressing cells in microdroplet ecosystems to screen for functional antibodies .
Integration of CA4 antibodies into advanced imaging techniques can provide valuable insights into protein distribution and function:
Super-resolution microscopy: Techniques like STORM or PALM can localize CA4 at nanometer resolution, revealing detailed membrane organization
Intravital microscopy: Labeled CA4 antibodies can track protein dynamics in living tissues
ImmunoPET: Radiolabeled CA4 antibodies could potentially be used for positron emission tomography imaging, though this requires careful consideration of radiolabeling strategies
When designing immunoPET applications, researchers must consider factors such as:
Appropriate radionuclide selection based on the biological half-life of antibodies
Optimization of injected dose to achieve sufficient signal-to-noise ratio
Development of image analysis protocols for quantitative assessment
Site-specific modification enables precise engineering of antibodies with enhanced functionality:
Quadruple-functionalisation: Recent advances allow attachment of up to four different functional groups at distinct sites on a single antibody molecule
Orthogonal modification strategies: Combining multiple chemical approaches enables selective modification at different antibody regions
Applications to CA4 antibodies: These technologies could create multi-functional CA4 antibody conjugates that simultaneously:
Bind CA4 with high specificity
Carry imaging agents for visualization
Deliver therapeutic payloads
Include additional targeting moieties
For example, recent research has demonstrated the development of homogeneous multi-payload antibody-drug conjugates (ADCs) using site-specific protein modification strategies, including cyclopropenone (CPO)-based reagents . These approaches could potentially be applied to CA4 antibodies to create multifunctional research tools or therapeutic candidates.
High background is a common challenge in immunostaining procedures. For CA4 antibodies, consider these remediation strategies:
Increase blocking stringency: Extend blocking time to 2 hours and use a combination of normal serum and BSA
Optimize antibody concentration: Perform titration experiments to identify minimum effective concentration
Modify washing protocols: Increase wash duration and buffer volume between antibody incubations
Reduce secondary antibody concentration: Dilute secondary antibodies further to minimize non-specific binding
Use specialized blocking reagents: Commercial protein-free blockers or specialized formulations may reduce background
Researchers should note that background issues may be particularly pronounced in tissues with high endogenous biotin or peroxidase activity, requiring specific blocking steps depending on the detection system used.
Sample variability can significantly impact experimental outcomes. When working with CA4 antibodies:
Standardize sample processing: Develop consistent protocols for sample collection, fixation, and storage
Include internal controls: Process control samples alongside experimental samples in each experiment
Normalize quantitative data: Use housekeeping proteins or total protein staining for accurate normalization
Consider biological variables: Account for variables such as tissue origin, donor characteristics, and disease state
Document methodological details: Record all experimental parameters to identify sources of variability
Establishing robust standard operating procedures (SOPs) and quality control checkpoints is essential for generating reproducible results across different experimental batches.
CA4 antibodies have emerging applications in clinical research contexts:
Biomarker development: Investigating CA4 expression patterns in various pathological conditions
Diagnostic tool development: Exploring CA4 as a potential diagnostic marker in specific diseases
Therapeutic target validation: Assessing CA4 as a potential therapeutic target
While CA4-specific antibodies have not been extensively used in direct therapeutic applications, the methodologies developed for other monoclonal antibody therapies provide valuable insights. For instance, therapeutic monoclonal antibodies have shown potential in treating various conditions, including COVID-19 in high-risk patients with hematologic malignancies .
Multiplexed systems allow simultaneous detection of multiple targets:
Antibody species selection: Choose primary antibodies raised in different host species to enable specific secondary antibody detection
Fluorophore selection: Select fluorophores with minimal spectral overlap for clear signal separation
Sequential staining: Consider sequential rather than simultaneous staining for challenging combinations
Cross-reactivity testing: Validate the specificity of each antibody individually and in combination
Automated analysis: Develop robust image analysis workflows for quantifying complex staining patterns
Multiplexed approaches are particularly valuable for studying CA4 in the context of other proteins involved in pH regulation and acid-base homeostasis mechanisms.